Structure Therapeutics

Structure's platform combines the latest advances in molecular interaction visualization, computational chemistry, and data integration to develop differentiated drugs. With this technology, Structure aims to develop oral small-molecule drugs that can provide biologic-like activity and specificity while overcoming the limitations of current biologics and peptide drugs.Structure is advancing a differentiated therapeutic pipeline at the clinical stage, focusing on chronic diseases with unmet global needs, including cardiovascular, metabolic, and pulmonary conditions.